TROVAN Drug Patent Profile
✉ Email this page to a colleague
When do Trovan patents expire, and what generic alternatives are available?
Trovan is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.
Summary for TROVAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 873 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TROVAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TROVAN
US Patents and Regulatory Information for TROVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-001 | Dec 18, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | TROVAN PRESERVATIVE FREE | alatrofloxacin mesylate | INJECTABLE;INJECTION | 020760-002 | Dec 18, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | TROVAN PRESERVATIVE FREE | alatrofloxacin mesylate | INJECTABLE;INJECTION | 020760-001 | Dec 18, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | TROVAN/ZITHROMAX COMPLIANCE PAK | azithromycin dihydrate; trovafloxacin mesylate | FOR SUSPENSION, TABLET;ORAL | 050762-001 | Dec 18, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TROVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-001 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-001 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-001 | Dec 18, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TROVAN
See the table below for patents covering TROVAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 9602630 | ⤷ Try a Trial | |
Norway | 300214 | ⤷ Try a Trial | |
Czech Republic | 9601625 | ⤷ Try a Trial | |
Finland | 108228 | ⤷ Try a Trial | |
Mexico | 9709873 | NUEVA FORMA CRISTALINA DEL ACIDO 7([1(ALFA),5(ALFA),6(ALFA)]-6-AMINO-3-AZABICICLO[3.1.0]HEX-3 -IL)-6-FLUOR-1-(2,4-DIFLUOROFENIL)1,4-DIHIDRO-4-OXO-1,8-NAFT IRIDIN-3-CARBOXILICO ANIHDRO, SAL DEL ACIDO METANO-SULFONICO, COMPOSICIONES QUE LA CONTIENEN, Y (NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1'alpha', 5'alpha', 6'alpha']-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2 ,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CAR BOXYLIC ACID, METHANESULFONIC ACID SALT.) | ⤷ Try a Trial |
South Korea | 19990068014 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TROVAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0413455 | SPC/GB98/045 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TROVAFLOXACIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR THE MESYLATE SALT.; REGISTERED: CH 54483 19980327; UK EU/1/98/059/001 19980703; UK EU/1/98/059/002 19980703; UK EU/1/98/059/003 19980703; UK EU/1/98/059/004 19980703; UK EU/1/98/059/005 19980703; UK EU/1/98/059/006 19980703; UK EU/1/98/059/007 19980703; UK EU/1/98/059/008 19980703; UK EU/1/98/059/009 19980703; UK EU/1/98/059/010 19980703; UK EU/1/98/059/011 19980703; UK EU/1/98/059/012 19980703 |
0413455 | SPC/GB98/046 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ALATROVAFLOXACIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR THE MESYLATE SALT.; REGISTERED: CH 54484 19980327; UK EU/1/98/060/001 19980703; UK EU/1/98/060/002 19980703; UK EU/1/98/060/003 19980703 |
0413455 | 98C0040 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ALATROFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/060/001 19980327; FIRST REGISTRATION: CH 54484 19980327 |
0413455 | 98C0039 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TROVAFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/059/001 19980703; FIRST REGISTRATION: CH 54483 19980327 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |